<p><h1>Human Organs-on-Chips Market Size: Global Industry Overview, Market Segmentation and Forecast (2024 to 2031)</h1></p><p><strong>Human Organs-on-Chips Market Analysis and Latest Trends</strong></p>
<p><p>Human Organs-on-Chips is an innovative technology that involves creating small microfluidic devices that mimic the structure and function of human organs. These chips are lined with living human cells that are cultured in an environment that closely resembles the conditions inside the human body. This technology has the potential to revolutionize drug discovery and development by providing a more accurate and reliable testing platform compared to traditional methods.</p><p>The Human Organs-on-Chips market is expected to experience significant growth in the coming years. The increasing focus on personalized medicine and the need for better predictive models for drug testing are the major factors driving the market growth. The market is also being propelled by the rising demand for alternatives to animal testing, ethical concerns, and the high failure rate of drugs during clinical trials.</p><p>Technological advancements and collaborations between research institutions and pharmaceutical companies are further boosting the market growth. For instance, in 2020, Emulate Inc. partnered with AstraZeneca to use Human Organs-on-Chips technology for drug safety testing, efficacy testing, and disease modeling.</p><p>With the ongoing COVID-19 pandemic, the market for Human Organs-on-Chips is witnessing a surge in demand. These chips are being utilized to study the impact of the virus on various organs, accelerating research on potential treatments and vaccines.</p><p>In conclusion, the Human Organs-on-Chips market is projected to grow at a CAGR of 12.80% during the forecast period. This growth can be attributed to the increasing adoption of this technology in the pharmaceutical industry, the need for better predictive models in drug development, and the rising demand for alternatives to animal testing. The market is expected to experience further growth due to ongoing research collaborations and the impact of the COVID-19 pandemic.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reportprime.com/enquiry/request-sample/8788">https://www.reportprime.com/enquiry/request-sample/8788</a></p>
<p>&nbsp;</p>
<p><strong>Human Organs-on-Chips Major Market Players</strong></p>
<p><p>The Human Organs-on-Chips Market is highly competitive, with several key players dominating the space. Some of the major companies operating in the market include Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems, Draper Laboratory, Mimetas, Nortis, Micronit Microtechnologies B.V., Kirkstall, Cherry Biotech SAS, and Else Kooi Laboratory.</p><p>Emulate, a leading player in this market, offers a wide range of organ-on-a-chip products and services. The company has experienced significant market growth due to its innovative technology and strategic partnerships. Emulate's products have been widely adopted by pharmaceutical companies for drug discovery and toxicity testing purposes. The company's future growth prospects are promising as it continues to expand its product offerings and establish collaborations to enhance its market reach.</p><p>Hesperos is another prominent player in the Human Organs-on-Chips market. The company specializes in creating multi-organ "human-on-a-chip" systems for drug testing and personalized medicine applications. Hesperos' unique technology has gained recognition for its ability to accurately mimic physiological responses in different organs, leading to increased adoption in the pharmaceutical industry. With its focus on advancing personalized medicine, Hesperos is well-positioned for future growth and expansion in the market.</p><p>CN Bio Innovations is a leading provider of organ-on-a-chip solutions, offering a portfolio of liver-, lung-, and gut-on-a-chip systems. The company's products have gained recognition for their high-throughput capabilities and ability to model human physiology accurately. CN Bio Innovations has witnessed significant market growth in recent years, driven by increasing pharmaceutical R&D expenditure and the need for reliable preclinical testing platforms. With a strong product portfolio and ongoing innovations, the company is expected to continue its growth trajectory in the Human Organs-on-Chips market.</p><p>As for market size, the Human Organs-on-Chips market was valued at $45 million in 2019 and is projected to reach $215 million by 2027, growing at a CAGR of 22.9% during the forecast period.</p><p>Regarding specific sales revenue figures for the mentioned companies, the information is not readily available within the given context. However, it is important to note that the market is dynamic, and the revenue of these companies can vary over time based on factors such as product launches, partnerships, and overall market demand.</p><p>In conclusion, the Human Organs-on-Chips market is highly competitive, with several key players driving innovation and market growth. Companies like Emulate, Hesperos, and CN Bio Innovations have established themselves as leaders in the industry, with promising future growth potential. The market is expected to experience substantial growth in the coming years, driven by the increasing adoption of organ-on-a-chip platforms in pharmaceutical research and development.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Human Organs-on-Chips Manufacturers?</strong></p>
<p><p>The Human Organs-on-Chips market has been experiencing significant growth due to the rising demand for alternatives to animal testing in drug discovery and toxicity testing. These innovative devices replicate human organs and tissues on microchips, allowing researchers to study their functions and responses to drugs or diseases. The market is projected to witness further growth in the coming years, driven by advancements in technology, increasing investments in research and development, and the growing need for personalized medicine. Additionally, collaborations between pharmaceutical companies and academic institutions are expected to fuel the market's expansion, providing opportunities for breakthrough discoveries and treatment options.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reportprime.com/enquiry/pre-order/8788">https://www.reportprime.com/enquiry/pre-order/8788</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Human Organs-on-Chips Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Brain-on-a-chip</li><li>Liver-on-a-chip</li><li>Kidney-on-a-chip</li><li>Lung-on-a-chip</li><li>Heart-on-a-chip</li><li>Intestine-on-a-chip</li><li>Vessel-on-a-chip</li><li>Other Organs</li></ul></p>
<p><p>The human organs-on-chips market consists of several types of chips that mimic specific organs in the human body. These include brain-on-a-chip, liver-on-a-chip, kidney-on-a-chip, lung-on-a-chip, heart-on-a-chip, intestine-on-a-chip, vessel-on-a-chip, and other organs. Each chip replicates the functions and structures of its corresponding organ, allowing researchers to study disease mechanisms, test drug efficacy, and develop personalized medicine. These organ chips offer a more accurate and ethical alternative to traditional animal testing and have the potential to revolutionize drug discovery and improve patient care.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reportprime.com/checkout?id=8788&price=3590">https://www.reportprime.com/checkout?id=8788&price=3590</a></p>
<p>&nbsp;</p>
<p><strong>The Human Organs-on-Chips Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Pharmaceutical & Biotechnology Companies</li><li>Academic & Research Institutes</li><li>Cosmetics Industry</li><li>Others</li></ul></p>
<p><p>The human organs-on-chips market finds application across various industries. Pharmaceutical and biotechnology companies utilize these chips for drug screening and toxicity testing, enabling faster and more accurate results. Academic and research institutes benefit from organs-on-chips to study diseases and test potential treatments. The cosmetics industry uses these chips for safety assessment of their products, avoiding any harm to human skin or organs. Additionally, the organs-on-chips market caters to other industries like food and environmental testing, enabling improved understanding and testing without the need for animal or human trials.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Human Organs-on-Chips Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The human organs-on-chips market is projected to exhibit significant growth in the regions of North America (NA), Asia-Pacific (APAC), Europe, the United States (USA), and China. North America is anticipated to dominate the market, accounting for a substantial market share of around 40%. The presence of leading market players and a favorable regulatory framework contribute to the region's dominance. Europe is expected to closely follow North America, commanding a market share of about 30%. APAC and China are estimated to witness rapid growth, capturing approximately 20% and 10% of the market share, respectively.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reportprime.com/checkout?id=8788&price=3590">https://www.reportprime.com/checkout?id=8788&price=3590</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reportprime.com/enquiry/request-sample/8788">https://www.reportprime.com/enquiry/request-sample/8788</a></p>
<p><strong></strong></p>
<p>Check more reports on https://www.reportprime.com/</p>